Myristic Acid and Its Salts and Esters: CIR Safety Assessment Summary
CIR safety assessment summary for Myristic Acid and Its Salts and Esters: ingredients reviewed, panel verdict, use concentration context, conditions, and.
Myristic Acid and Its Salts and Esters appears in a CIR safety assessment covering Myristic Acid and Its Salts and Esters. The panel verdict for the report is safe. Reference n-Butyl alcohol 112; 29 (addendum) 0.1%-10%; 0.000007%-15% Safe in nail preparations in the current practices of use. 2,3 Cetyl alcohol 2694; 2931 (re-review) >0.1%-50%; 0.000002%-15% Safe as cosmetic ingredients in the current practices of use.
| Field | CIR value |
|---|---|
| Primary ingredient | Myristic Acid and Its Salts and Esters |
| CIR verdict | safe |
| Report type | Final Report |
| Date | In 1990 |
| CAS numbers | 544-63-8, 56639-51-1, 4040-50-0, 110-36-1, 15284-51-2, 2599-01-1, 41927-71-3, 124-06-1, 29806-75-5, 53563-63-6, 589-68-4, 27214-38-6, 25263-97-2, 83708-66-1, 17670-91-6, 51473-24-6, 110-27-0, 72576-81-9 |
| Use concentration context | 0.000007%-15% Safe in nail preparations in the current practices of use. |
| Conditions or carve-outs |
Ingredients Reviewed
The review scope matters because CIR conclusions often apply to an ingredient family rather than a single INCI name. In this report, the ingredient list includes Myristic Acid and Its Salts and Esters.
Safety Conclusion
The conclusion for Myristic Acid and Its Salts and Esters should be read as a CIR panel conclusion, not a regulatory limit. CIR assessments summarize expert-panel safety determinations for cosmetic use, while legal status still depends on the jurisdiction and product category.
For use levels, the report gives this concentration context: 0.000007%-15% Safe in nail preparations in the current practices of use.. That language is the safe-use context shown for this page.
Conditions
Reference n-Butyl alcohol 112; 29 (addendum) 0.1%-10%; 0.000007%-15% Safe in nail preparations in the current practices of use.
Formulation Reading
For formula review, begin with the exact INCI identity and the ingredient group covered by the CIR assessment. If the material is Myristic Acid and Its Salts and Esters, the relevant comparison is whether the intended use aligns with the practices, concentration ranges, and conditions described in the CIR source.
The ingredient hub at Myristic Acid and Its Salts and Esters should carry the substance-level profile. This page is the report-level summary, keeping the conclusion, ingredient scope, and use-context language attached to the CIR source rather than treating the conclusion as a universal permission.
Why This Page Exists
CIR reviews are long documents, and the practical answer is usually buried in the conclusion and the table of current practices. This summary keeps those CIR facts in one indexable page for Myristic Acid and Its Salts and Esters, with source details retained at the bottom for audit.
Source
- CIR report: Final Report of the Amended Safety Assessment of Myristic Acid and Its Salts and Esters as Used in Cosmetics Lillian C. Becker1, Wilma F. Bergfeld, MD, FACP2, Donald V. Belsito, MD2, Ronald A. Hill, PhD2, Curtis D. Klaassen, PhD2, James G.
- CIR source file: PRS504.pdf
- Extraction JSON: CIR Safety Assessment Database
- Conclusion page in CIR extraction: 3